基于(关键地区、市场参与者、规模和份额)的人乳头瘤病毒 (HPV) 疫苗市场 - 到 2031 年的预测

  • Report Code : TIPRE00029411
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 277
Buy Now

2022年人乳头瘤病毒(HPV)疫苗市场价值为42.7384亿美元,预计到2028年将达到57.305亿美元;预计 2022 年至 2028 年复合年增长率为 5.0%。

人乳头瘤病毒 (HPV) 是一组感染粘液的基于 DNA 的病毒以及人类和各种动物的皮肤膜。已对 100 多种不同类型的 HPV 进行了表征。 HPV 引起的各种癌症的患病率不断上升,预计将在预测期内推动人乳头瘤病毒 (HPV) 疫苗市场的发展。根据美国疾病控制与预防中心 (CDC) 的数据,HPV 是美国最常见的性传播感染。超过60%的阴茎癌、70%的外阴癌和阴道癌、90%的肛门癌和宫颈癌都是由HPV感染引起的。 CDC 还表示,美国每年约有 1,400 万人新感染该病毒。

战略见解

全球人乳头瘤病毒 ( HPV)疫苗市场根据类型、剂量、年龄、分销渠道和地理位置进行细分。按地区划分,市场分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。该报告对人乳头瘤病毒(HPV)疫苗市场提供了见解和深入分析,强调了市场趋势、技术进步和市场动态等各种参数。它还包括全球领先市场参与者的竞争格局分析。

人乳头瘤病毒 (HPV) 疫苗市场利润丰厚的区域

< h3 class="MsoNormal">市场洞察
HPV 相关流行率增加疾病

人乳头瘤病毒 (HPV) 是一种常见的性传播感染,可导致宫颈癌、口咽癌以及阴道癌、外阴癌、阴茎癌或肛门癌。它还会引起各种疾病,例如肛门生殖器疣和复发性呼吸道乳头状瘤病。硬化性地衣、皮赘、脂溢性角化病、表皮囊肿、光化性角化病和银屑病斑块中也检测到了 HPV。 HPV 相关疾病的巨大负担可能会推动市场的增长。

在女性中,宫颈癌是第四大常见癌症。据世界卫生组织(WHO)报告估计,2018年,全球估计有57万名女性患有宫颈癌,约31.1万名女性因宫颈癌死亡。此外,美国临床肿瘤学会 (ASCO) 估计,仅在美国就登记了约 14,100 例浸润性宫颈癌病例。此外,根据《欧盟 27 国宫颈癌负担》报告,2020 年,女性因宫颈癌新增病例 30,447 例,死亡 13,437 例。

此外,根据癌症中心的数据美国疾病控制与预防 (CDC) 数据显示,2018 年,美国约有 4300 万 HPV 感染者。 CDC 还估计,每年约有 19,400 名女性和 12,100 名男性患有 HPV 引起的癌症。此外,根据国家传染病基金会 (NFID) 的数据,美国每年约有 1400 万新的 HPV 感染病例。此外,根据题为“欧洲人类乳头瘤病毒和相关疾病报告”的报告,2020 年,欧洲有 8,449 名女性和 4,327 名男性患有肛门癌。

全球 HPV 相关感染的发病率如此之高,可能有利于未来几年的整体市场增长。

基于类型的见解
基于类型,人类乳头瘤病毒(HPV)疫苗市场分为九价HPV疫苗、四价HPV疫苗和二价HPV疫苗。 2022年,四价HPV疫苗细分市场占据最大市场份额。然而,9 价 HPV 疫苗市场预计将在 2022 年至 2028 年快速增长。四价人乳头瘤病毒 (HPV) 疫苗可预防 6、11、16 和 18 型 HPV 感染,这些病毒是导致70% 至 80% 的宫颈癌和至少 90% 的尖锐湿疣病例。该疫苗可降低病毒引起的尖锐湿疣以及宫颈癌、阴道癌和外阴癌前驱病变的风险。
                                           全球人乳头瘤病毒 (HPV) 疫苗市场(按应用) 2022 年和 2028 年

基于剂量的见解

根据剂量,人乳头瘤病毒 (HPV) 疫苗市场分为2剂和3剂。到 2022 年,2 剂量细分市场将占据更大的市场份额。

基于年龄的见解

基于年龄的全球人乳头瘤病毒 (HPV) 疫苗市场,分为9至14岁和15至45岁。 9 至 14 岁细分市场将在 2022 年占据更大的市场份额,并且预计该细分市场在预测期内将实现更高的复合年增长率。

基于应用的洞察

从应用来看,全球人乳头瘤病毒(HPV)疫苗市场分为HPV相关癌症和尖锐湿疣。 HPV 相关癌症细分市场将在 2022 年占据更大的市场份额,并且预计该细分市场在预测期内将实现更高的复合年增长率。

基于分销渠道的见解

根据分销渠道,全球人乳头瘤病毒 (HPV) 疫苗市场分为医生办公室、社区卫生诊所、学校卫生中心、卫生部门、医院等。到 2022 年,医院细分市场将占据最大的市场份额,而学校健康中心细分市场预计在预测期内的复合年增长率最高。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the human papillomavirus vaccine market?

Human papillomaviruses is a diverse group of DNA-based viruses that infect the mucous and skin membranes of humans and various animals. More than 100 different types of human papillomavirus have been characterized. Increasing prevalence of various cancers caused by human papillomavirus is expected to drive the market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), human papillomavirus is the most common sexually transmitted infection in the U.S. Over 60% of penile cancers, 70% of vulvar and vaginal cancers, and 90% of anal and cervical cancers are caused due to human papillomavirus infection. CDC also states that about 14 million people are newly infected by human papillomavirus every year in the U.S.

What are the driving factors for the human papillomavirus vaccine market across the country?

Driving factor such as increase in prevalence of HPV associated diseases and initiatives taken by global health organizations are likely to have a positive impact on the growth of the global human papillomavirus (HPV) vaccines market. Whereas factors, such as growing number of HPV awareness programs, are likely to create a growth opportunity on the HPV vaccines market in the near future.

Who are the major players in market the human papillomavirus vaccine market?

The human papillomavirus vaccine market majorly consists of the players such Merck & Co. In., GSK, Serum Institute of India, Walvax Biotechnologies, Innovax, Vaccitech, Innovio Pharmaceuticals, Chengdu Institute of Biological Products Co., Ltd., Sanofi, R-Pharm, Shanghai Bowei, and Bioleaders amongst others.

Which segment is dominating the human papillomavirus vaccine market?

The human papillomavirus vaccine market, by type, is bifurcated 9-valent HPV vaccine, quadrivalent HPV vaccine, and bivalent HPV vaccine. In 2022, the quadrivalent HPV vaccine segment held the largest share of the market, by type. However, the 9-valent HPV vaccine segment is expected to witness the fastest growth during 2022 to 2028.

The List Of Companies - HPV Vaccines Market

  1. Merck & Co. In.
  2. GSK
  3. Serum Institute of India
  4. Walvax Biotechnologies
  5. Innova
  6. Vaccitech
  7. Innovio Pharmaceuticals
  8. Chengdu Institute of Biological Products Co., Ltd.
  9. Sanofi
  10. R-Pharm
  11. Shanghai Bowei
  12. Bioleaders

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports